Cargando…
Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects
BACKGROUND: This study compared efficacy and safety of the selective relaxant binding agent sugammadex (2 mg/kg) with neostigmine (50 μg/kg) for neuromuscular blockade (NMB) reversal in Chinese and Caucasian subjects. METHODS: This was a randomized, active-controlled, multicenter, safety-assessor-bl...
Autores principales: | Wu, Xinmin, Oerding, Helle, Liu, Jin, Vanacker, Bernard, Yao, Shanglong, Dahl, Vegard, Xiong, Lize, Claudius, Casper, Yue, Yun, Huang, Yuguang, Abels, Esther, Rietbergen, Henk, Woo, Tiffany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153006/ https://www.ncbi.nlm.nih.gov/pubmed/25187755 http://dx.doi.org/10.1186/1471-2253-14-53 |
Ejemplares similares
-
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013) -
Sugammadex is effective in reversing rocuronium in the presence of antibiotics
por: Hudson, Mark E, et al.
Publicado: (2014) -
Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery
por: Alsaeed, Abdulhamid, et al.
Publicado: (2017) -
SUGAMMADEX versus neostigmine after ROCURONIUM continuous infusion in patients undergoing liver transplantation
por: Deana, Cristian, et al.
Publicado: (2020) -
Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)